Paper6402289
Definitive nonsurgical therapy of epithelial malignancies of the anal canal. A report of 12 cases.
Flam MS and 8 others. Cancer, 1983. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. Definitive nonsurgical therapy of epithelial malignancies of the anal canal. A report of 12 cases. Papers, record 6402289. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6402289
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Definitive nonsurgical therapy of epithelial malignancies of the anal canal. A report of 12 cases.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Anus Neoplasms | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Fluorouracil | Major topic |
| Mitomycins | Major topic |
| Adult | |
| Aged | |
| Brachytherapy | |
| Drug Therapy, Combination | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Leukocyte Count | |
| Male | |
| Middle Aged | |
| Mitomycin | |
| Neoplasm Recurrence, Local | |
| Platelet Count | |
| Prognosis | |
| Radiotherapy, High-Energy |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33801992 | Evolution of the Role of Radiotherapy for Anal Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33801992 | PubMed |
| 31288054 | Executive Summary of the American Radium Society Appropriate Use Criteria for Treatment of Anal Cancer. | Int J Radiat Oncol Biol Phys | 2019 | https://conductscience.org/library/papers/31288054 | PubMed |
| 25008956 | Optimal treatment strategies for anal cancer. | Curr Treat Options Oncol | 2014 | https://conductscience.org/library/papers/25008956 | PubMed |
| 24558509 | ACR Appropriateness Criteria®-Anal Cancer. | Gastrointest Cancer Res | 2014 | https://conductscience.org/library/papers/24558509 | PubMed |
| 16227631 | State of the art: gastrointestinal malignancies in the human immunodeficiency virus (HIV) population. | Int J Gastrointest Cancer | 2005 | https://conductscience.org/library/papers/16227631 | PubMed |
| 1546901 | Combined chemoradiation therapy for anal cancer. A report of 56 cases. | Ann Surg | 1992 | https://conductscience.org/library/papers/1546901 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6402289
GET https://conductscience.org/api/papers/v1/6402289/authors